A new treatment for asthma and COPD attacks could revolutionise patient care, scientists say. An injection given during ...

Argenx’s investigational therapy, subcutaneous efgartigimod alfa, has been granted Promising Innovative Medicine (PIM) status ...

Cytomos has announced that it has raised $5m in an oversubscribed funding round to scale up production of its cell analysis ...

A precise and realistic TPP can define a clear path to market and commercial success by bridging the gap between research and ...

Eran Harary, Senior Vice President of Global Early Clinical Development at Teva, said: “This collaboration will provide ...

How industry and the NHS can work together to bridge the diagnostic gap in COPD Lord Darzi’s recent report on the state of ...

Process efficiencies – QR codes provide a continuous gateway to the latest PI, reducing the time spent to produce and approve ...

The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles ...

Tessellate BIO has appointed Dr Lara Boyd as Chief Business Officer.

Commit Biologics has announced the appointment of Mikkel Wandahl Pedersen as Chief Scientific Officer (CSO). Mikkel is a ...

PharmaTimes Marketer of the Year Awards and Communications Awards ...

Our luminaries look across the pharmaverse with conclusions and curiosity ...